| Host: |
Rabbit |
| Applications: |
WB/ELISA |
| Reactivity: |
Human/Rat/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-RNA binding protein fox-1 homolog 1 (50-130 aa) is suitable for use in Western Blot and ELISA research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:500-2000ELISA 1:5000-20000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
RBFOX1 |
| Gene ID: |
54715 |
| Uniprot ID: |
RFOX1_HUMAN |
| Immunogen Region: |
50-130 aa |
| Specificity: |
RFOX1 Polyclonal Antibody detects endogenous levels of protein. |
| Immunogen: |
Synthesized peptide derived from the human protein at the amino acid range 50-130 |
| Function | RNA-binding protein that regulates alternative splicing events by binding to 5'-UGCAUGU-3' elements. Regulates alternative splicing of tissue-specific exons and of differentially spliced exons during erythropoiesis. |
| Protein Name | Rna Binding Protein Fox-1 Homolog 1Ataxin-2-Binding Protein 1Fox-1 Homolog AHexaribonucleotide-Binding Protein 1 |
| Database Links | Reactome: R-HSA-9022707 |
| Cellular Localisation | NucleusCytoplasm |
| Alternative Antibody Names | Anti-Rna Binding Protein Fox-1 Homolog 1 antibodyAnti-Ataxin-2-Binding Protein 1 antibodyAnti-Fox-1 Homolog A antibodyAnti-Hexaribonucleotide-Binding Protein 1 antibodyAnti-RBFOX1 antibodyAnti-A2BP antibodyAnti-A2BP1 antibodyAnti-FOX1 antibodyAnti-HRNBP1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
